Chairman, Virokine Therapeutics

Edward D Blair, PhD MBA is currently Chairman of Virokine Therapeutics, Board Trustee at the Quadram Institute and contracted-in neurosciences biomarker strategist at UCB Pharma. He is also a visiting scholar to Cambridge University where he teaches on two Masters courses.

Much of his scientific career has been spent within or adjacent to the pharmaceutical industry where Eddie has been involved in target & drug discovery through clinical trials to product launch & commercialisation.

During a gap in his time within pharma, Eddie developed novel ideas generated by public sector agencies to found, launch or grow innovative SME’s, and retains close associations with innovation through serving on several grant awarding committees. In addition to a recently-acquired MBA in business finance & strategy, Eddie has a PhD in virology and has worked in several therapeutic areas notably infectives, oncology, liver & kidney disease and neurodegeneration.

Eddie has raised £15M+ in investment, including an executive role in an IPO, holds several granted but assigned patents, and has more than 50 peer-reviewed publications.


20 May 2021